Ignite Creation Date:
2025-12-24 @ 5:29 PM
Ignite Modification Date:
2025-12-31 @ 9:14 AM
Study NCT ID:
NCT01243268
Status:
COMPLETED
Last Update Posted:
2018-10-22
First Post:
2010-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Regulatory Requirement Post-Marketing Surveillance Study to Monitor the Safety and Efficacy of Twynsta (Telmisartan + Amlodipine SPC, q.d.) in Korean Hypertensive Patients Requiring Combination Therapy
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-12-21
Start Date Type:
ACTUAL
Primary Completion Date:
2016-06-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-08-18
Completion Date Type:
ACTUAL
First Submit Date:
2010-11-17
First Submit QC Date:
None
Study First Post Date:
2010-11-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-06-23
Results First Submit QC Date:
None
Results First Post Date:
2018-10-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-14
Last Update Post Date:
2018-10-22
Last Update Post Date Type:
ACTUAL